SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Gold/Mining/Energy : Nuvo Research Inc

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: russet who wrote (8583)1/29/2002 8:58:08 PM
From: Mark Bartlett  Read Replies (2) of 14101
 
russett,

With all do respect, you can take almost any drug, including water itself, and turn it into a potentially dangerous chemical.

It all boils down to a benefit analysis -- and that is what the trials are for. The first trial (phase 1) measures the teratogenicity, mutagenicity and carcinogenicity of the drug. They use certain cell lines that are approved for measuring changes in these areas. If it does not pass these preliminary tests, that is generally the end of the line. As far as I know, DMSO would have had to pass these tests just like any other drug.

The Cox 2s were approved with 6 months data. Should Pennsaid be subjected to a different amount of time? Do not forget that these trials are designed with the FDA's input, not in a vacuum.

I hear what you are saying, but all one has to do is read the warning labels on most approved drugs to see that they all have some negative elements.

NSAIDS rut your gut, cholesterol drugs come with a higher rate of suicide (bet you did not know that) Vicks vapour rub can cause rashes, antiretrovirals directly impact the DNA/RNA and raise lipid levels, the antibiotic rifampin knocks out your RNA -- and on the list goes.

MB
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext